Rheumatoid arthritis finding may lead to new inflammation blockers

ROCHESTER, Minn. — Mayo Clinic researchers have linked the T cell dysfunction seen in rheumatoid arthritis with a metabolic deficiency in a new Nature Immunology publication. In "helper" T cells from patients with rheumatoid arthritis, low levels of a specific amino acid lead to cellular miscommunication, but supp lying it may provide a new therapeutic strategy for autoimmune disease. Rheumatoid arthritis is an autoimmune disorder characterized by chronic inflammation, including high levels of a cytokine called…
Source: Mayo Clinic Minnesota News - Category: Hospital Management Source Type: news